Literature DB >> 12707458

Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy.

P Kinrions1, N Ibrahim, K Murphy, A-E Lehesjoki, I Järvela, N Delanty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12707458     DOI： 10.1212/01.wnl.0000058755.38892.80

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

Review 1.  Update on Pharmacological Treatment of Progressive Myoclonus Epilepsies.

Authors:  Edoardo Ferlazzo; Dorothee Kasteleijn-Nolst Trenite; Gerrit-Jan de Haan; Felix Felix Nitschke; Saija Ahonen; Sara Gasparini; Berge A Minassian
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

2.  Role of levetiracetam in refractory seizures due to a rare progressive myoclonic epilepsy: Lafora body disease.

Authors:  Mubashira Hashmi; Feroza Saleem; Muhammad Shahid Mustafa; Mughis Sheerani; Zeeshan Ehtesham; Khurram Siddiqui
Journal:  BMJ Case Rep       Date:  2010-11-05

3.  Levetiracetam in three cases of progressive myoclonus epilepsy.

Authors:  Savvas Papacostas; Elena Kkolou; Eleftherios Papathanasiou
Journal:  Pharm World Sci       Date:  2007-01-23

4.  Progressive myoclonic epilepsy type 1: Report of an Emirati family and literature review.

Authors:  Mohammed Saadah; Mahfoud El Beshari; Loai Saadah; Hisham Hamdallah; Zeinab Alloub; Amani Ali Al Zaabi; Abdelmatlob Ben-Mussa; Anwaar Ben-Nour
Journal:  Epilepsy Behav Case Rep       Date:  2014-05-04

Review 5.  Progressive myoclonic epilepsy.

Authors:  Mary L Zupanc; Benjamin Legros
Journal:  Cerebellum       Date:  2004       Impact factor: 3.648

6.  Levetiracetam in the treatment of epilepsy.

Authors:  Bassel Abou-Khalil
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.